Compare ADMA Biologics Inc (ADMA) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Aterian Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: ADMA Biologics Inc is far larger — about 417.3× Aterian Inc's market cap. Which is the better fit depends on your goals.
| ADMA | ATER | |
|---|---|---|
Market Cap | $2.22B | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $1.39 |
52-Week Low | $7.60 | $0.36 |
Enterprise Value | $2.29B | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
